Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Free Report) CFO Erick Lucera sold 1,991 shares of the company's stock in a transaction dated Friday, November 13th. The stock was sold at an average price of $16.82, for a total transaction of $33,488.62. Following the completion of the transaction, the...